Ablation of Osteopontin Improves the Skeletal Phenotype of Phospho1−/− Mice
暂无分享,去创建一个
[1] J. Millán,et al. In Vivo Overexpression of Tissue‐Nonspecific Alkaline Phosphatase Increases Skeletal Mineralization and Affects the Phosphorylation Status of Osteopontin , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] M. McKee,et al. Compounded PHOSPHO1/ALPL Deficiencies Reduce Dentin Mineralization , 2013, Journal of dental research.
[3] G. Hunter. Role of Osteopontin in Modulation of Hydroxyapatite Formation , 2013, Calcified Tissue International.
[4] J. Millán. The Role of Phosphatases in the Initiation of Skeletal Mineralization , 2012, Calcified Tissue International.
[5] Nick Bishop,et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. , 2012, The New England journal of medicine.
[6] M. McKee,et al. Loss of Skeletal Mineralization by the Simultaneous Ablation of PHOSPHO1 and Alkaline Phosphatase Function: A Unified Model of the Mechanisms of Initiation of Skeletal Calcification , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] Simon R. Goodyear,et al. PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures. , 2010, Bone.
[8] Jeffrey J. Gray,et al. Phosphorylation‐dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] R. Terkeltaub,et al. Inorganic pyrophosphatase induces type I collagen in osteoblasts. , 2010, Bone.
[10] R. Terkeltaub,et al. Enzyme Replacement Therapy for Murine Hypophosphatasia , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[11] A. Evan,et al. Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both. , 2007, American journal of physiology. Renal physiology.
[12] M. McKee,et al. Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase Activity* , 2007, Journal of Biological Chemistry.
[13] J. Millán,et al. Functional Involvement of PHOSPHO1 in Matrix Vesicle–Mediated Skeletal Mineralization , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] C. Farquharson,et al. The presence of PHOSPHO1 in matrix vesicles and its developmental expression prior to skeletal mineralization. , 2006, Bone.
[15] R. Terkeltaub,et al. Elevated Skeletal Osteopontin Levels Contribute to the Hypophosphatasia Phenotype in Akp2−/− Mice , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] M. McKee,et al. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. , 2005, Genes & development.
[17] R. Terkeltaub,et al. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. , 2004, The American journal of pathology.
[18] R. Terkeltaub,et al. Linked Deficiencies in Extracellular PPi and Osteopontin Mediate Pathologic Calcification Associated With Defective PC‐1 and ANK Expression , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] A. Boskey,et al. Osteopontin Facilitates Bone Resorption, Decreasing Bone Mineral Crystallinity and Content During Calcium Deficiency , 2003, Calcified Tissue International.
[20] C. Alpers,et al. J Am Soc Nephrol 14: 139–147, 2003 Osteopontin Is a Critical Inhibitor of Calcium Oxalate Crystal Formation and Retention in Renal Tubules , 2022 .
[21] M. McKee,et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. , 2002, The American journal of pathology.
[22] R. Guldberg,et al. Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein–deficient Mice , 2002, The Journal of experimental medicine.
[23] R. Terkeltaub,et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Boskey,et al. Osteopontin Deficiency Increases Mineral Content and Mineral Crystallinity in Mouse Bone , 2002, Calcified Tissue International.
[25] S. Narisawa,et al. Abnormal vitamin B6 metabolism in alkaline phosphatase knock‐out mice causes multiple abnormalities, but not the impaired bone mineralization , 2001, The Journal of pathology.
[26] D. Denhardt,et al. Osteopontin Function in Pathology: Lessons from Osteopontin-Deficient Mice , 1999, Nephron Experimental Nephrology.
[27] M. McKee,et al. Mice Lacking Osteopontin Show Normal Development and Bone Structure but Display Altered Osteoclast Formation In Vitro , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] T. Ushida,et al. Osteopontin involvement in integrin‐mediated cell signaling and regulation of expression of alkaline phosphatase during early differentiation of UMR cells , 1997, FEBS letters.
[29] P. Højrup,et al. Posttranslational modifications of bovine osteopontin: Identification of twenty‐eight phosphorylation and three O‐glycosylation sites , 1995, Protein science : a publication of the Protein Society.
[30] G. Hunter,et al. Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. , 1994, The Biochemical journal.
[31] A. Boskey,et al. Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. , 1993, Bone and mineral.
[32] R. Schrohenloher,et al. Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. , 1987, The Journal of biological chemistry.
[33] D. Heinegård,et al. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[34] W. Mcalister,et al. Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: results in three additional patients. , 1984, The Journal of pediatrics.
[35] W. Mcalister,et al. Infantile hypophosphatasia: enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone disease. , 1982, The Journal of pediatrics.